MetabolicResearch strength: PreliminaryEvidence: Preliminary
Pancragen
Pancragen (Lys-Glu-Asp-Trp, KEDW)
Also known as: KEDW
A Khavinson tetrapeptide sold as a pancreatic bioregulator riding the metabolic-health wave; preclinical, single-group evidence only.
Overview
Pancragen is claimed to support pancreatic function and glucose regulation. The literature is limited to cell and animal reports from the originating institute. No human trial, no independent replication, no pharmacokinetics.
Mechanism of action
Proposed modulation of pancreatic cell gene expression.
Key studies & citations
- Review2020
Peptide bioregulators: the Khavinson corpus (review)
Single-lineage evidence base.
Stem Cell Reviews and Reports
Frequently asked questions
Does Pancragen lower blood sugar in people?
No human study has tested it.